GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » CONX Corp (NAS:CONXU) » Definitions » Research & Development

CONX (CONXU) Research & Development : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is CONX Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CONX's Research & Development for the three months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


CONX Research & Development Historical Data

The historical data trend for CONX's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CONX Research & Development Chart

CONX Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
- - - -

CONX Quarterly Data
Aug20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CONX Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CONX  (NAS:CONXU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


CONX Research & Development Related Terms

Thank you for viewing the detailed overview of CONX's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


CONX (CONXU) Business Description

Traded in Other Exchanges
Address
5701 South Santa Fe Drive, Littleton, CO, USA, 80120
Website
CONX Corp is a blank check company.
Executives
Jericho Capital Asset Management L.p. 10 percent owner 510 MADISON AVENUE, 27TH FLOOR, NEW YORK NY 10022
Josh Resnick 10 percent owner 510 MADISON AVENUE, 27TH FLOOR, NEW YORK NY 10022
Louis M Bacon 10 percent owner 11 TIMES SQUARE, 39TH FLOOR, MOORE CAPITAL MANAGEMENT LP, NEW YORK NY 10036
Moore Capital Advisors Llc 10 percent owner 11 TIMES SQUARE, 39TH FLOOR, NEW YORK NY 10036
Moore Capital Management, Lp 10 percent owner 11 TIMES SQUARE, 39TH FLOOR, NEW YORK NY 10036
Mmf Lt, Llc 10 percent owner C/O MOORE CAPITAL MANAGEMENT, LP, 11 TIMES SQUARE, NEW YORK NY 10036
Moore Global Investments, Llc 10 percent owner C/O MOORE CAPITAL MANAGEMENT, LP, 11 TIMES SQUARE, NEW YORK NY 10036
David K Moskowitz director C/O CONX CORP., 5701 S. SANTA FE DR., LITTLETON CO 80120
Adrian Steckel director 5701 S. SANTA FE DR., LITTLETON CO 80120
Charles W Ergen director, 10 percent owner, officer: Chairman 9601 S. MERIDIAN BLVD., ENGLEWOOD CO 80112
Gerald Gorman director 5701 S. SANTA FE DR., LITTLETON CO 80120
Nxgen Opportunities, Llc 10 percent owner 5701 S. SANTA FE DR., LITTLETON CO 80120
Kyle Jason Kiser director, officer: CEO, President & Director 5701 S. SANTA FE DR., LITTLETON CO 80120